details

Peer companies

;

Share Market News

The Revenue for the quarter ended  December 2017 of Rs. 2733.90 millions grew by 10.49 % from Rs. 2474.30 millions.Net Profit witnessed a 155.48% growth almost the double from Rs. 46.50 millions to Rs. 118.80  millions  of same quarter last year.Operating profit for the quarter ended December 2017 rose to 521.60 millions as compared to 332.80 millions of corresponding quarter ended December 2016. (Rs. in Million) Quarter ended Year to Date Year ended 201712 201612 % Var 201712 201612 % Var 201703 201603 % Var Sales 2733.90 2474.30 10.49 7700.70 7460.80 3.22 9069.20 8163.90 11.09 Other Income 17.10 13.50 26.67 52.60 38.10 38.06 86.50 53.40 61.99 PBIDT 521.60 332.80 56.73 1427.60 1031.70 38.37 1389.10 1122.10 23.79 Interest 120.10 137.80 -12.84 351.50 406.00 -13.42 497.80 381.00 30.66 PBDT 401.50 195.00 105.90 1076.10 625.70 71.98 891.30 741.10 20.27 Depreciation 134.60 115.50 16.54 385.90 346.40 11.40 466.10 354.70 31.41 PBT 266.90 79.50 235.72 690.20 279.30 147.12 425.20 386.40 10.04 TAX 148.10 33.00 348.79 285.20 125.70 126.89 177.30 84.30 110.32 Deferred Tax 94.90 12.80 641.41 146.50 64.00 128.91 91.30 8.00 1041.25 PAT 118.80 46.50 155.48 405.00 153.60 163.67 247.90 302.10 -17.94 Equity 918.16 828.60 10.81 918.16 828.60 10.81 872.30 828.60 5.27 PBIDTM(%) 19.08 13.45 41.85 18.54 13.83 34.06 15.32 13.74 11.44

Sree Rayalaseema Alkalies & Allied Chemicals is currently trading at Rs. 26.70, up by 0.70 points or 2.69% from its previous closing of Rs. 26.00 on the BSE.The scrip opened at Rs. 27.50 and has touched a high and low of Rs. 27.60 and Rs. 26.30 respectively. So far 519254 shares were traded on the counter.The BSE group `XC` stock of face value Rs. 10 has touched a 52 week high of Rs. 29.10 on 26-Oct-2016 and a 52 week low of Rs. 17.00 on 22-Nov-2016.Last one week high and low of the scrip stood at Rs. 28.30 and Rs. 25.35 respectively. The current market cap of the company is Rs. 232.02 crore.The promoters holding in the company stood at 54.79%, while institutions and non-institutions held 0.73% and 44.48% respectively.Sree Rayalaseema Alkalies & Allied Chemicals has posted over 2-fold jump in its net profit at Rs 5.94 crore for the quarter ended March 31, 2017 as compared to Rs 2.23 crore for the same quarter in the previous year. Total income from operations of the company increased marginally by 2.57% at Rs 232.38 crore for quarter under review as compared to Rs 226.55 crore for the quarter ended March 31, 2016. For the year ended March 31, 2017, the company has posted a fall of 20.39% in its net profit at Rs 19.44 crore as compared to Rs 24.42 crore in FY16. However, total income from operations of company increased by 11.09% at Rs 906.92 crore for year under review as compared to Rs 816.39 crore for the year ended March 31, 2016.

Sree Rayalaseema Alkalies & Allied Chemicals has submitted the Shareholding Pattern for the Period Ended December 31, 2016. The above information is a part of company’s filings submitted to BSE.

Sree Rayalaseema Alkalies & Allied Chemicals has informed that the Board Allotment Committee Meeting will be held on January 13, 2016 to consider issue and allotment of 1,30,95,272 Convertible Share Warrants having face value of Rs 10 each in three tranches at an issue price of Rs 17.02 (as approved by the shareholders in the Annual General Meeting held on September 16, 2015) on Preferential basis to Brilliant Industries, (Promoter) pursuant to SEBI (ICDR) Regulations, 2009.The above information is a part of company’s filings submitted to BSE.

Sree Rayalaseema Alkalies & Allied Chemicals has informed that the Board of Directors have vide their meeting held on October 13, 2015 and effective from December 01, 2015, constituted a Disclosure Committee comprising of Key Managerial Personnel’s of the Company.The above information is a part of company’s filings submitted to BSE.

Sree Rayalaseema Alkalies & Allied Chemicals has informed about the standalone financial results for the period ended September 30, 2015.The above information is a part of company’s filings submitted to BSE.

Sree Rayalaseema Alkalies & Allied Chemicals has submitted a copy of Newspaper Advertisement for ensuing Annual General Meeting to be held on September 16, 2015.The above information is a part of company’s filings submitted to BSE.

IDBI Bank has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011.The above information is a part of company’s filings submitted to BSE.

Sree Rayalaseema Alkalies & Allied Chemicals has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.The above information is a part of company’s filings submitted to BSE.

Sree Rayalaseema Alkalies & Allied Chemicals has informed that J. Nagabhushanam has been co-opted as Additional Director by the Board in its meeting held on July 10, 2015 and also the Board noted the withdrawal of Shalini Soni from the Board by IFCI Limited vide their letter dated June 19, 2015.The above information is a part of company’s filings submitted to BSE.

Sree Rayalaseema Alkalies & Allied Chemicals has informed about the Standalone Financial Results for the period ended June 30, 2015.The above information is a part of company’s filings submitted to BSE.

Sree Rayalaseema Alkalies & Allied Chemicals has informed about the Standalone Financial Results & a copy of the Limited Review Report for the period ended December 31, 2014.The above information is a part of company’s filings submitted to BSE.